|
Isradipine trial fails - no significant benefits
As John posted on in the previous thread, the isradipine trial results have been released. Unfortunately the drug had no significant benefits. As this was a very closely watched trial by the PD community, it's sad and I thought it deserved discussion on a new thread.
Well, onto the next trial. One of these days we will succeed! Gary Calcium Channel Blocker Flops in Parkinson's Disease Trial | Medpage Today |
| All times are GMT -5. The time now is 09:28 AM. |
Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.